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Introduction
The eukaryotic cell cycle comprises the alternation between 
DNA replication and chromosome segregation and is driven by 
the Cyclin–Cdk family of protein kinases (Morgan, 2007). Most 
eukaryotic cells have multiple Cyclin–Cdks that are active at 
different stages of the cell cycle, but in essence, the control of 
the cell cycle can be reduced to an oscillation in Cyclin–Cdk 
activity: low activity allows the loading and firing of DNA rep-
lication origins, whereas high activity prevents origin loading 
and promotes mitosis (Noton and Diffley, 2000). In mammalian 
cells, mouse knockout studies have demonstrated that only a 
single Cdk, Cdk1, is essential for the cell cycle in the develop-
ing embryo (Santamaría et al., 2007), but it is not known which 
cyclins are essential to drive the cell cycle, particularly mitosis.
There are two classes of mitotic cyclins: the A- and the 
B-type cyclins. There are two closely related B-type cyclins in 
mammalian cells (a third Cyclin, named B3, is only distantly 
related by sequence and is restricted to germ cells; Nguyen et 
al., 2002). Cyclin B1 is essential for mouse development, be-
cause no homozygous Cyclin B1–null embryos are recovered at 
embryonic day 10 (Brandeis et al., 1998). In contrast, Cyclin B2 
appears to be redundant in the mitotic cell cycle; the knockout 
mouse has no phenotype except a smaller litter size (Brandeis 
et al., 1998). The likely explanation for the primacy of Cyclin 
B1 is that whereas Cyclin B1 shuttles between the nucleus and 
the cytoplasm in interphase and binds to the mitotic apparatus 
in mitosis, Cyclin B2 is localized primarily to the Golgi ap-
paratus (Jackman et al., 1995) and thus cannot phosphorylate 
the majority of substrates recognized by Cyclin B1. Indeed, the 
localization of the B-type cyclins is crucial to their function; in 
the absence of other B-type cyclins, Cyclin B2 can only affect 
the structure of the Golgi apparatus, whereas Cyclin B1 can re-
organize the cytoskeleton and disassemble the nuclear lamina 
(Draviam et al., 2001). Similarly, frog Cyclin B can promote 
DNA replication when it is targeted into the nucleus by replac-
ing its N terminus with that from Cyclin E (Moore et al., 2003).
Using a Cyclin B1–Cdk1–specific Förster resonance 
energy transfer (FRET) sensor, we found that human Cyclin 
B1–Cdk1 was first activated ∼20 min before nuclear envelope 
breakdown (NEBD), and upon activation, the complex im-
mediately began to move into the nucleus (Gavet and Pines, 
2010b). This redistribution to the nucleus has been suggested 
to be important to impose switch-like behavior on mitotic entry 
(Santos et al., 2012). Earlier studies had found that a consti-
tutively nuclear Cyclin B1 did not perturb cell cycle timing, 
but combining this with a Cdk1 that was insensitive to Wee1 
inhibition (Cdk1, T14A, and Y15F) caused premature mitotic 
entry (Jin et al., 1998).
Although Cyclin B1 is essential for mouse development, 
it is not known when it is first required. It may be essential for 
cell division from fertilization onward, like Cdk1 (Santamaría 
et al., 2007), or only later in development, like Cyclin A2 (Mur-
phy et al., 1997). Until recently, the B-type cyclins were thought 
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to be essential for mitosis in most organisms, except Drosoph-
ila melanogaster, where only Cyclin A is required (Lehner and 
O’Farrell, 1990; Jacobs et al., 1998). With the advent of RNAi, 
however, this notion has been challenged in mammalian cells. 
Several studies have reported that cells are still able to enter mi-
tosis after depletion of Cyclin B1 (Bellanger et al., 2007; Gong 
et al., 2007; Soni et al., 2008; Gong and Ferrell, 2010). Thus, 
it has been proposed that, as in Drosophila, mammalian Cyclin 
B1 may be redundant with Cyclin A2 or with Cyclin A in coop-
eration with Cyclin B2 (Bellanger et al., 2007; Soni et al., 2008).
One important caveat to RNAi studies, however, is that 
they do not completely deplete a protein; therefore, with an en-
zyme such as a protein kinase, the small amount of protein that 
remains may provide sufficient activity to fulfill its function. A 
definitive answer to the question of whether Cyclin B1 is essen-
tial for cell division requires a true genetic null; therefore, we 
have analyzed the early cell cycles of Cyclin B1–null embryos 
using a mouse knockout line that was generated by Brandeis et 
al. (1998). In addition to defining the requirement for Cyclin B1 
in mitosis, we have also explored the importance of the spatial 
control of Cyclin B1 in regulating mitosis. Here, we show that 
cells cannot divide without Cyclin B1; in the absence of Cyclin 
B1, cells arrest at the four-cell stage in G2 phase after DNA 
replication. Furthermore, we have developed a novel imaging 
approach to exploit this clean genetic background as a system in 
which we can analyze specific aspects of Cyclin B1 function by 
comparing the effects of injecting mRNA encoding wild type 
with mutant forms of Cyclin B1. These experiments demon-
strate that the nuclear export of Cyclin B1 is crucial for the 
correct timing of mitotic entry, because constitutively nuclear 
Cyclin B1 promotes early entry to mitosis even when bound 
to endogenous Cdk1 that is sensitive to regulation by Wee1. In 
comparison, preventing Cyclin B1–Cdk1 from freely diffusing 
in the cytoplasm prevents its ability to promote mitosis.
Results
Embryos arrest at the four-cell stage 
without Cyclin B1
To determine the role of Cyclin B1 in cell division, we analyzed 
the early development of embryos from a Cyclin B1–knockout 
mouse line (Brandeis et al., 1998; gift of T. Hunt, Clare Hall 
Laboratories, London, England, UK). Brandeis et al. (1998) 
were unable to recover Cyclin B1−/− embryos at embryonic day 
10 but did not establish why embryos failed to develop to this 
stage. Thus, it was important to determine when the absence of 
Cyclin B1 prevented further development and whether this was 
because of an inability to divide or the consequence of com-
promised divisions or some other function of Cyclin B1 that 
became important between fertilization and day 10.
Cyclin B1+/− heterozygotes are fully viable; therefore, we 
set up crosses to obtain embryos with +/+, +/−, and −/− (null) 
Cyclin B1 genotypes for analysis. To determine when the Cy-
clin B1−/− embryos stopped developing, we cultured zygotes in 
vitro for 3.5 d up to the blastocyst stage and, in parallel, used 
time-lapse imaging of embryos to characterize the mitotic divi-
sions. We did not have a live-cell marker for the deletion; there-
fore, we had to determine the genotype of the embryos at the 
end of the experiment using a PCR protocol specifically for low 
and variable amounts of DNA (see Fig. S1 A and Materials and 
methods). To facilitate analysis in live-imaging experiments, we 
developed an imaging device, which we called the Multiwell 
Immobilization and Imaging, or MI2, Chip (Dolomite Micro-
fluidics). Using this device, we could culture and image large 
numbers of embryos at high resolution for several days and re-
cover each embryo for genotyping at the end of the experiment 
(Materials and methods and Fig. S1 B).
After 3.5 d of culture, we found that the great majority 
(92%, n = 83) of Cyclin B1–null embryos had arrested before 
or at the four-cell stage (Fig. 1 A, left). 75% of Cyclin B1–null 
embryos arrested exactly at the four-cell stage, but in rare cases, 
one (6%) or two (2%) of the blastomeres at the four-cell stage 
underwent one additional division (Fig. 1 A right). Thus, Cyclin 
B1–null embryos had the earliest arrest phenotype of any Cy-
clin knockout analyzed to date.
Cyclin B1–null embryos undergo two 
normal divisions
To determine why embryos stopped dividing in the absence 
of Cyclin B1, we compared the development of wild-type and 
Cyclin B1–null embryos by high-resolution time-lapse imaging 
and found their divisions to be indistinguishable in timing and 
morphology up to the four-cell stage (Fig. 1 B and Video 1). (It 
should be noted that blastomere divisions are not synchronous 
in the mouse embryo, and the onset of division at any given 
round of division can vary up to several hours between embryos 
of the same litter; Bischoff et al., 2008.) After the second di-
vision, however, Cyclin B1–null embryos stopped dividing, 
whereas the wild-type and heterozygote embryos continued to 
develop up to the blastocyst stage (Video 1). Although the Cy-
clin B1–null embryos arrested, they showed no obvious signs 
of deterioration or apoptosis. Moreover, we noted that the Cy-
clin B1−/− embryos appeared to undergo compaction at approx-
imately the same time as wild-type embryos (when the latter 
reached the mid-to-late eight-cell stage). Thus, consistent with 
earlier studies (Day et al., 1998; Goval and Alexandre, 2000), 
the timing mechanism for compaction appeared to be indepen-
dent of cell division in the mouse embryo.
To analyze cell division in Cyclin B1−/− embryos in greater 
detail, we injected zygotes with synthetic mRNA encoding his-
tone H2B-RFP to visualize the chromosomes. Time-lapse im-
aging showed that chromosome condensation, alignment, and 
segregation were indistinguishable between wild-type and Cy-
clin B1−/− embryos during the first two divisions (Video 2 and 
Fig.  1  C). Once the Cyclin B1−/− embryos had arrested after 
the second division, however, it was noticeable that in 80% of 
embryos, the chromatin underwent partial condensation and 
decondensation to varying degrees in one or more of the blas-
tomeres (Fig. 1 C and Video 2). These condensations, however, 
did not progress to the pattern of chromosome condensation in 
late prophase wild-type cells, and the nuclear envelope never 
broke down. These partial chromosome condensation events 
might have been caused by residual maternal Cyclin B1 RNA 
or possibly by rising levels of Cyclin A2–Cdk activity. Simi-
larly, differences in the degree of chromosome condensation 
between blastomeres might have been caused by variable lev-
els of residual Cyclin B1 message. To address this, we mea-
sured Cyclin B1 mRNA levels in four-cell–arrested embryos 
using quantitative single-embryo RT-PCR. We measured LacZ 
transcript levels as a marker for Cyclin B1+/− and Cyclin B1−/− 
embryos and found that there was a bimodal distribution of Cy-
clin B1 levels in LacZ-positive embryos (Table S1); Cyclin B1 
mRNA was either not detectable above background or present 
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Figure 1. Cyclin B1−/− embryos arrest at the four-cell stage after two normal divisions. (A) Zygotes obtained from crosses of viable Cyclin B1+/− mice were 
cultured up to 3.5 d in vitro (left). Out of 83 Cyclin B1 homozygous–null embryos, 92% arrest at the four-cell stage or earlier (23 independent experiments). 
Distribution of the number of blastomeres found in Cyclin B1−/− embryos (right); 75% arrest at the four-cell stage; in 6% of embryos, one (or in 2%, two) 
blastomeres can divide once more. (B) Differential interference contrast time-lapse imaging of a wild-type (top) and a Cyclin B1−/− embryo (bottom) from 
the same litter (bar, 20 µm; time in hours :minutes). Representative frames from Video 1 shown from the late two-cell stage till the beginning of the 32-cell 
stage and blastocoel formation. No difference in the temporal dynamics of the first two divisions was observed between wild-type and knockout embryos, 
but the Cyclin B1−/− embryo arrests after the second division. (C) H2B-RFP mRNA was injected into zygotes to visualize DNA in wild-type (top) and Cyclin 
B1−/− embryos (bottom). Representative frames from Video 2, shown from the late two-cell stage until the blastocyst stage. Chromosome condensation, 
metaphase plate formation, and chromosome segregation were indistinguishable between wild-type and Cyclin B1−/− embryos. In 80% of cases (five of six 
embryos in three independent experiments), arrested Cyclin B1−/− embryos showed variable and transient rounds of incomplete chromatin condensation 
in one or more blastomeres (see time point 27 h:20 min, bottom, and Video 2). Bar, 20 µm. Time in hours :minutes.
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at 100- to 1,000-fold greater levels. Because the DNase1 treat-
ment required for RT-PCR precludes direct genotyping, we 
interpret this as the difference between the Cyclin B1−/− and 
the Cyclin B1+/− embryos.
Cyclin B1–null embryos cannot complete 
entry to mitosis even when antagonistic 
phosphatases are inhibited
For cells to enter mitosis, it is not sufficient simply to activate 
Cyclin B1–Cdk1; the phosphatases that antagonize Cyclin B–
Cdk1 must also be inhibited to prevent a futile cycle, and this 
is achieved by an inhibitor generated by the Greatwall kinase 
(Castilho et al., 2009; Gharbi-Ayachi et al., 2010; Mochida et 
al., 2010). This raised the possibility that another Cyclin–Cdk 
might be able to drive cells into mitosis in the absence of Cyclin 
B1 if we inhibited PP2A; indeed, inhibiting protein phospha-
tases with okadaic acid (OA) can overcome the cell cycle arrest 
in mouse spermatocytes lacking Cyclin A1 and drive them into 
meiosis (Liu et al., 2000). As OA has been used previously in 
mammalian cells and mouse oocytes to inhibit PP2A (Chang et 
al., 2011), we used arrested mouse oocytes as an assay system 
and established that 250 nM OA induced NEBD (germinal vesi-
cle breakdown; Fig. S2A). Therefore, we treated Cyclin B1–null 
embryos arrested at the four-cell stage with 250 nM OA and as-
sayed the effect by time-lapse microscopy. After 20 h, 80% (n = 
15) of Cyclin B1–null embryos remained arrested with uncon-
densed or only partially condensed chromatin. Only in 20% of 
embryos, which could have had a higher residual level of Cyclin 
B1 maternal mRNA, did the chromatin condense and disperse 
(Fig. S2 B; and Video 3, middle). To analyze the phenotypes 
further, we coinjected Cyclin B1–null embryos with EB3-GFP 
and H2B-RFP. Fig. S2 (C and D) and Videos 4 and 5 show that 
the nuclear envelope did break down in the majority of cells, in-
dicated by the entry of tubulin into the nuclear region, but cells 
made no attempt to organize a spindle. In the minority of cells 
where condensed DNA dispersed, disorganized microtubule 
bundles formed transiently but without organizing into a proper 
spindle structure. Thus, we conclude that Cyclin B1 is required 
to complete mitotic entry even in the absence of antagonistic 
PP2A phosphatase activity.
Cyclin B2 does not make an apparent 
contribution to early cell divisions
Our results showed that mouse Cyclin B1 is essential in the ear-
liest cell divisions and that from the four-cell stage onward, its 
function cannot be replaced by Cyclin A2 or B2. Brandeis et 
al. (1998) previously showed that Cyclin B2 was not essential 
for development, but later siRNA studies in cell culture con-
cluded that Cyclin B2 could compensate for Cyclin B1 in mito-
sis (Bellanger et al., 2007; Soni et al., 2008). It was important, 
therefore, to assess whether Cyclin B2 made any contribution to 
driving the second division in Cyclin B1−/− embryos.
We crossed Cyclin B2−/− mice (a gift of T.  Hunt) with 
Cyclin B1+/− mice and analyzed the development of the Cyclin 
B1−/−/Cyclin B2−/− embryos. If Cyclin B2 contributes effec-
tively to the first two divisions, then one would expect that these 
embryos would either arrest at an earlier stage or exhibit more 
compromised second divisions. We found, however, that the 
Cyclin B1/B2 double-knockout embryos showed the same ar-
rest phenotype as the Cyclin B1–knockout embryos at the four-
cell stage (Fig. S3). Thus, it appears that in the embryo Cyclin 
B2 does not compensate for Cyclin B1 in promoting mitosis.
Cyclin B1–null embryos arrest after 
completing S phase
Our imaging data showed that Cyclin B1−/− embryos exited mi-
tosis normally at the second division. Therefore, we wished to 
establish at which stage cells arrested in the next cell cycle in 
the absence of Cyclin B1. To achieve this, we used proliferating 
cell nuclear antigen (PCNA) as a marker to analyze S phase 
entry and progression. PCNA, an essential component of the 
replication machinery, localizes to replication foci, and PCNA 
foci can be used as a marker for cells in S phase (Leonhardt et 
al., 2000); the size and distribution pattern of foci can even be 
used to distinguish between early, mid-, and late S phase cells.
To our knowledge PCNA had not previously been used 
to study S phase in live early mouse embryos. Therefore, we 
first had to establish the normal pattern of foci distribution. We 
microinjected embryos with synthetic mRNA encoding RFP-
PCNA and analyzed the fluorescence pattern by high-resolution 
live-cell imaging. This showed that early mouse embryos ex-
hibited the characteristic progression of foci patterns reported 
in cultured mammalian cells (Leonhardt et al., 2000): the sud-
den appearance of many evenly distributed, small foci marked S 
phase onset, followed by reorganization from mid- through late 
S phase into progressively fewer, bigger foci mainly localized 
around nucleoli and at the nuclear periphery, until all foci dis-
appeared at the end of S phase (Fig. 2 A). In G1 and G2 phases, 
the PCNA signal showed homogenous nuclear distribution, and 
the nuclear signal was lost at NEBD and reappeared when the 
nuclear membrane reformed in telophase.
To determine the exact cell cycle stage when cells ar-
rested in the absence of Cyclin B1, we injected RFP-PCNA 
at the zygote stage and followed development by time-lapse 
fluorescence imaging. After the second division, the nuclei of 
wild-type and Cyclin B1−/− embryos passed through a very 
short G1 phase of ∼20 min and began to form small replication 
foci that subsequently developed into progressively bigger and 
fewer foci, indicating that the nuclei were proceeding through S 
phase (Fig. 2 B and Video 6). Comparing wild-type and Cyclin 
B1–null embryos showed that there was no apparent difference 
in the timing of DNA replication or patterns of foci, but once 
the last focus had disappeared, marking the end of S phase, the 
nuclei of the Cyclin B1–null embryos arrested with the homog-
enous nuclear distribution of PCNA characteristic of G2 phase.
Cyclin B1–null embryos are not arrested by 
a Wee1-dependent checkpoint
It was possible that the Cyclin B1–null embryos arrested in G2 
phase as a consequence of activating a checkpoint because of in-
complete DNA replication or DNA damage rather than the lack 
of Cyclin B1. To test this, we inhibited the Wee1 kinase, which 
is required for the unreplicated and DNA damage checkpoints 
that prevent mitotic entry by phosphorylating Cyclin B1–Cdk1 
(Russell and Nurse, 1987; Enoch and Nurse, 1990; O’Connell 
et al., 1997; van Vugt et al., 2004). Adding the Wee1 inhibitor 
MK1775 (Hirai et al., 2009) dramatically shortened G2 phase 
to ∼30 min (31 ± 16 min [mean ± SD]) in wild-type and het-
erozygous embryos (n = 23, measured at the 8-cell to 16-cell 
transition in five independent experiments), which is only 25% 
of the expected length of G2 phase (for control G2 timing, see 
Fig. 6, A and B). Despite this effect, adding the inhibitor to four-
cell Cyclin B1−/− embryos only led to the initiation of prophase 
events as seen with OA; it did not induce normal chromosome 
condensation, alignment, or metaphase plate formation in 12 
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out of 13 embryos (four independent experiments), although 
in some blastomeres, the chromosomes did partially condense 
(Fig. 2 C and Video 7). Thus, Cyclin B1−/− embryos are not held 
in G2 phase by a Wee1-dependent checkpoint.
Cyclin B1 is essential for mitosis
All our results indicated that Cyclin B1 was essential for cells 
to begin mitosis. To test this and to establish whether Cyclin 
B1–null embryos could be used to study aspects of Cyclin B1 
function and regulation, we performed “rescue” experiments 
by injecting synthetic mRNA into zygotes, or into one blasto-
mere at the two-cell stage. Injecting synthetic mRNA encoding 
Cyclin B1 drove Cyclin B1–null embryos through up to three 
further divisions to the 32-cell stage and blastocyst formation 
(Fig. 3 A and Video 8). We measured the amount of Cyclin B1–
Venus protein translated from injected mRNA and compared 
Figure 2. Cyclin B1−/− embryos arrest in G2 phase after completing S phase. (A) Progress through S phase in the early mouse embryo can be monitored 
by injection of RFP-PCNA mRNA. The characteristic patterns of PCNA foci during S phase, and its homogenous distribution in G1 and G2 phases, were 
used to analyze the timing of different cell cycle phases in the early embryo. Bar, 10 µm. (B) Zygotes were injected with RFP-PCNA and representative 
frames of the Cyclin B1−/− embryo in Video 9 are shown from the two-cell stage until the corresponding wild-type reaches the blastocyst stage (bar, 20 µm). 
Enlarged inserts on top shows how one nucleus progresses normally through S phase after the second division and then arrests with homogenous PCNA 
distribution indicative of G2 phase (n = 5 embryos in three independent experiments). Bar, 10 µm (insets). (C) Representative frames of the RFP channel 
in Video 7. One blastomere was injected with H2B-RFP mRNA at the two-cell stage. Wee1 inhibitor was added to arrested Cyclin B1–null embryos at 
the time when wild-type embryos had started the four- to eight-cell division. Inhibitor was added during first time point. Wild-type (top) and Cyclin B1−/− 
(middle) chromatin condensation and some dispersal indicating NEBD (1 of 13 embryos); Cyclin B1−/− (bottom): chromatin condensation but no dispersal. 
Bar, 20 µm; time in hours :minutes.
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this to endogenous levels by immunoblotting (Fig. S4 A). We 
found that Cyclin B1–Venus was expressed at levels very simi-
lar to the amount of endogenous Cyclin B1 protein in wild-type 
embryos and that endogenous Cyclin B1 protein was itself sup-
pressed in these injected embryos (Fig. S4 C).
To analyze more accurately the ability of Cyclin B1 to 
drive cell division, we coinjected wild-type Cyclin B1 mRNA 
with mRNA encoding fluorescent markers of chromatin (his-
tone H2B), microtubules (β-tubulin; not depicted), or rep-
lication foci (PCNA; Fig. 3 B and Video 9). We injected the 
synthetic mRNAs into only one blastomere of a two-cell Cyclin 
B1−/− embryo to provide us with an internal control; the unin-
jected blastomere usually divided only once and then arrested, 
whereas the injected blastomeres continued to divide up to 
three more times. In total, 78% (n = 51) of injected embryos 
underwent at least one complete division beyond the four-cell 
arrest stage (Fig. 3 C, left); ∼25% of these divided twice and 
25% three times (Fig. 3 C, right). Thus, we conclude that the 
G2 phase arrest of Cyclin B1−/− cells can be rescued by injec-
tion of Cyclin B1 mRNA and that Cyclin B1 is essential for 
cells to enter mitosis.
Small amounts of Cyclin B1 are sufficient 
to trigger mitosis
The question now arose of how to reconcile our results with 
those from siRNA experiments in tissue culture cells, where 
Figure 3. Cyclin B1–null embryos can be driven through up to three divisions by injecting wild-type Cyclin B1 mRNA. (A) Wild-type mouse Cyclin B1–
Venus mRNA (mB1-Venus) was injected into both blastomeres at the two-cell stage. Representative frames of Video 8 are shown, beginning at the eight-cell 
stage; wild-type Cyclin B1–Venus (top) and transmitted light channels (bottom). Note the clearly visible nuclear import of Cyclin B1 before NEBD. Bar, 20 
µm. (B) Additional markers such as PCNA were coinjected with wild-type or mutant Cyclin B1 mRNA in one blastomere at the two-cell stage. Representative 
frames of Video 9 are shown, from the eight-cell stage onward. The two uninjected blastomeres, left of the white dotted line, serve as an internal control 
and remain arrested whereas the right half of the embryo progresses up to the 16-/32-cell stage. Top row shows channel merge of single plane through 
the center of the embryo; middle row shows projection of the RFP-PCNA channel. Bottom row shows projection of mB1-Venus channel (bar, 20 µm). 
(C) Quantification of rescue of Cyclin B1−/− embryos by injection of wild-type mouse Cyclin B1 mRNA; 78% of Cyclin B1−/− embryos divide beyond the 
arrest stage (taken as the six-cell stage to include the rare cases in which one or two blastomeres divide beyond the four-cell stage; n = 51, 10 independent 
experiments; left). Variation in the ability of injected wt mRNA to rescue (red bars, n = 51) compared with nonrescued Cyclin B1−/− embryos (blue bars, 
n = 83, 21 independent experiments; right); ∼25% of embryos respectively divided to the 8-cell stage, to the 16-cell stage, and up to the 32-cell stage.
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reducing Cyclin B1 to low levels had little apparent effect on 
the ability of cells to enter mitosis. One possibility is that only 
small amounts of Cyclin B1 are required for mitosis, which 
can be tested reliably only in a true null background. To pursue 
this, we tested whether there was a critical threshold of Cyclin 
B1 needed to trigger mitosis in the Cyclin B1−/− embryos. We 
injected different concentrations of synthetic mRNA encoding 
Cyclin B1–YFP into embryos and correlated the amount of Cy-
clin B1–YFP fluorescence with the ability to trigger mitosis. 
We found that a relatively clear but small threshold amount of 
Cyclin B1 was sufficient to trigger mitotic entry (Fig. 4 A).
We considered the possibility that the amount of Cy-
clin B1 necessary to trigger mitosis might be reduced fur-
ther in cells in which we inhibited Wee1, but we found that 
a similar threshold value of Cyclin B1 had to be reached in 
cells treated with the MK1775 inhibitor (Fig.  4  B). Treating 
wild-type embryos at different stages of the cell cycle with 
MK1775 showed that embryos from mid-S phase onward 
were able to enter mitosis, potentially indicating that the 
threshold of Cyclin B1 required for mitosis was reached in 
mid-S phase (Fig. 4, C–F).
Nuclear Cyclin B1 can drive mitosis in 
Cyclin B1−/− embryos
Our results revealed the potential to use Cyclin B1–null embryos 
as an experimental system to study Cyclin B1 function and regu-
lation by injecting mRNAs encoding mutant forms of Cyclin B1 
into a genetically null background. Moreover, the large cell size 
of the early mouse embryo makes this system particularly well 
suited to study spatial controls using a 3D imaging approach.
One of the most prominent characteristics of Cyclin B1 is 
its dynamic localization throughout the cell cycle. We and others 
have shown that Cyclin B1 shuttles between the cytoplasm and 
the nucleus, but its greater rate of export over import ensures that 
the majority of Cyclin B1 is cytoplasmic throughout interphase 
(Hagting et al., 1998; Toyoshima et al., 1998; Yang et al., 1998). 
At mitosis, cytoplasmic Cyclin B1 is rapidly imported into the 
nucleus concomitant with the activation of its partner kinase, 
Cdk1 (Gavet and Pines, 2010a,b). Although we understand the 
mechanism by which Cyclin B1 is maintained in the cytoplasm, 
the function of this spatial distribution is still not understood. It 
has been variously suggested that the nuclear export of Cyclin 
B1 is required to prevent its S phase–promoting activity (Moore 
et al., 2003), or in parallel with phosphorylation on T14 and Y15 
of Cdk1 to be part of the mechanism to prevent entry to mitosis 
(Santos et al., 2012), in particular after DNA damage (Jin et al., 
1998), or to act as a spatial positive feedback loop to impose 
switch-like behavior on the entry to mitosis (Santos et al., 2012).
Previous studies on the role of Cyclin B1 localization in 
the cell cycle had been complicated by the presence of endoge-
nous Cyclin B1, but our genetic null system overcame this issue. 
Therefore, we injected synthetic mRNA encoding Cyclin B1 with 
a F146A substitution to inactivate its nuclear export sequence 
(Hagting et al., 1998) plus a 7–amino acid nuclear localization 
sequence (NLS) to ensure that Cyclin B1 remained in the nucleus 
throughout the cell cycle. This mutant is hereafter called nuclear 
Figure 4. Low amounts of Cyclin B1 are suf-
ficient to trigger mitosis and the threshold is 
reached by mid S phase. (A) To establish the 
threshold of Cyclin B1–Venus that can drive 
null cells into mitosis, fluorescence intensity 
was used as a read-out for the amount of pro-
tein and measured in individual blastomeres of 
−/− embryos; y axis arbitrary intensity units. 
The threshold concentration to trigger mitosis 
lies between 100 and 200 units above back-
ground intensity, corresponding to ∼1/10 of 
the sampled intensity range (n = 21 blasto-
meres from five experiments). (B) Wild-type 
Cyclin B1–Venus was injected into one blas-
tomere of −/− embryos at the two-cell stage 
to rescue the arrest phenotype. Signal intensity 
was measured at the 8- to 16-cell transition 
after addition of Wee1 inhibitor. Only injected 
cells with a Cyclin B1 level above a thresh-
old of ∼150 arbitrary units can be forced into 
mitosis by Wee1 inhibition; n = 17, 1 experi-
ment. Error bars are the SD of the mean. (C–F) 
To test whether there is a time dependency 
of the inhibitory phosphorylation of Cdk1 by 
Wee1 the inhibitor MK1775 was added at dif-
ferent phases of the cell cycle to +/+ and +/− 
embryos. (C) Inhibitor added during mitosis or 
G1. Only 30% of cells enter to mitosis. 70% of 
cells arrest after a variable S phase (n = 35, 
six experiments). (D) Inhibitor added during 
early S phase leads to mitotic entry during 
mid-S phase in most cases; 80% (n = 36; 
six experiments). (E) Inhibitor added during 
mid-S phase forces cells into mitosis mostly in 
mid- and late S (together 85%; n = 34, six 
experiments). (F) Inhibitor added during late 
S phase drives cells into mitosis mostly with 
a much shortened G2 (see text for details; 
n = 24, five experiments). ES, early S phase; 
LS, late S phase; MS, mid-S phase.  o
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Cyclin B1. To establish the effect on the cell cycle of retaining 
Cyclin B1 in the nucleus, we injected mRNA encoding wild-type 
or nuclear Cyclin B1 into one blastomere at the two-cell stage. In 
some embryos, H2B-RFP was coinjected to assess chromosome 
segregation and mitotic progression (Fig. 5 A and Video 10). 
These experiments showed that wild-type (cytoplasmic) and 
nuclear Cyclin B1 had very similar abilities to drive successful 
rounds of cell divisions (Fig. 5 B). Thus, at least in early embry-
onic divisions, it appears that the continual nuclear export of Cy-
clin B1 is not required for cells to progress through the cell cycle.
Nuclear Cyclin B1 accelerates entry 
into mitosis
Although both cytoplasmic and nuclear Cyclin B1 mRNAs 
could rescue up to three complete cell cycles, we wanted to de-
termine whether the localization of Cyclin B1 would affect cell 
cycle timing. Therefore, we coinjected mRNA encoding RFP-
PCNA as a marker to measure the lengths of the different cell 
cycle stages and analyzed the timing at the 8- to 16-cell division. 
We defined S phase as beginning with the appearance of PCNA 
foci and ending with their disappearance. The subsequent pe-
riod with a homogeneous nuclear PCNA signal was classified 
as G2 phase. We defined the onset of mitosis as the time point 
when the homogeneous PCNA nuclear signal was dispersed at 
NEBD and G1 phase as the time between the reappearance of 
the PCNA nuclear signal (after the nuclear envelope reformed) 
until the first appearance of replication foci. To our knowledge, 
this is the first attempt to measure the lengths of specific phases 
of the cell cycle in live preimplantation mouse embryos. The 
cell cycle timings that we measured (Fig. 6) agreed well with 
previous more indirect measures of cell cycle phase lengths in 
the early mouse embryo (Streffer et al., 1980).
In contrast to studies transfecting Cyclin B1 and Cdk1AF 
into human cells (Jin et al., 1998), our experiments showed that 
constitutively nuclear Cyclin B1 had little effect on the duration 
of mitosis (Fig. 6 A), nor did it appear to have any measurable 
effect on DNA replication, because both G1 and S phase du-
rations were the same as in embryos injected with wild-type 
Cyclin B1. Thus, unlike in Xenopus laevis embryos (Moore et 
al., 2003), it appears that mammalian Cyclin B1 does not have 
to be exported from the nucleus to prevent it interfering with 
DNA replication. Nuclear Cyclin B1 did, however, significantly 
accelerate entry to mitosis after the end of DNA replication, 
because G2 phase was 40% shorter than normal (Fig. 6 B), even 
though it had only endogenous Cdk1 to bind. Thus, in addition 
to Wee1/Myt1– and Cdc25-mediated regulation of Cdk1, Cy-
clin B1 must be exported into the cytoplasm for cells to regulate 
the correct timing of mitosis.
Figure 5. Nuclear Cyclin B1 can drive mitosis in Cyclin B1−/− embryos. (A) Frames of Video 10 are shown from the eight-cell stage onwards. Synthetic 
mRNAs encoding nuclear Cyclin B1 and H2B-RFP were injected in one blastomere at the two-cell stage. The uninjected half of the embryo is to the right of 
the dotted line, the injected half of the embryo divides up to the 16-/32-cell transition. Top row shows the channel merge of a single central plane through 
the embryo. Middle row shows projection of the H2B-RFP channel. Bottom row shows projection of the nuclear Cyclin B1 channel. (B) Comparison of rescue 
efficiency of wild-type (wt; blue, n = 51) and nuclear Cyclin B1 mRNA (red, n = 31, eight independent experiments) in driving Cyclin B1−/− embryos beyond 
the arrest stage (left). Comparison of the number of divisions that wild-type and nuclear Cyclin B1 can promote in Cyclin B1−/− embryos (right). Bar, 20 µm.
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Tethering Cyclin B1–Cdk1 to the plasma 
membrane prevents mitotic entry
As nuclear Cyclin B1 can trigger normal mitosis, and because 
its forced nuclear localization affects only the timing of mitotic 
entry, our results also indicate that nuclear Cyclin B1 alone can 
sufficiently activate Cdk1 and the relevant feedback loops re-
quired for mitotic entry. However, the importance of cytoplas-
mic spatial control to initiate early mitotic events before NEBD 
is still not well understood. This is difficult to study in systems 
without a clean genetic null background; therefore, we asked 
to what extent the nuclear–cytoplasmic localization of Cyclin 
B1 is essential to trigger the first events of mitotic entry by 
holding Cyclin B1 in the cytoplasm. To achieve this, we used a 
C-terminal Caax domain (Cyclin B1–RFP–Caax) to retain Cy-
clin B1 at the plasma membrane.
We first checked that membrane-tethered Cyclin B1 could 
bind to Cdk1 by staining embryos with anti-Cdk1 antibodies 
and found that expressing Cyclin B1–RFP–Caax caused some 
of the Cdk1 to relocalize to the plasma membrane (Fig.  7, 
A–D). Thus, tethering Cyclin B1 to the plasma membrane does 
not preclude it binding to Cdk1. (Note that our quantification 
of Cyclin B1 and Cdk1 levels in embryos showed that Cdk1 is 
in fourfold excess to Cyclin B1; therefore, only a minority of 
Cdk1 would be expected to relocalize to the membrane; Fig. S4, 
A and C.) Next we tested whether Cyclin B1–Caax could rescue 
Cyclin B1−/− embryos by injecting synthetic mRNA encoding 
Figure 6. Nuclear Cyclin B1 accelerates entry into 
mitosis. (A) The lengths of different phases of the cell 
cycle were quantified after injecting either PCNA 
alone (PCNA, green; three independent experiments), 
wild-type Cyclin B1 (mB1, blue; four independent 
experiments), or nuclear Cyclin B1 (B1NLS, red; five 
independent experiments). y axis shows time in min-
utes (mean; error bars represent ±SD of the mean) is 
shown for each of the genotypes: +/+ (wt), +/− (het), 
and −/− (ko). Numbers inside bars indicate number 
of divisions analyzed. (B) The greatest difference in 
timing between wild-type and nuclear Cyclin B1 was 
in G2 phase where nuclear Cyclin B1 reduced G2 
length by ∼40% (P < 0.0001, two-sided t test; error 
bars: ±SD of the mean; ****, P < 0.0001).
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Cyclin B1–RFP–Caax. As shown in Fig.  7 (E–G), wild-type 
and heterozygous embryos developed normally to the 32-cell 
stage, whereas Cyclin B1−/− embryos arrested in 90% of cases 
at the four-cell stage or earlier (Fig. 7, F and G), the normal 
time point for Cyclin B1−/− cells to arrest. The inability of mem-
brane-bound Cyclin B1–Cdk1 to drive mitosis could have dif-
ferent explanations, the most obvious of which was that it could 
not be activated. To assay this, we used our Cyclin B1–Cdk1 
FRET sensor (Gavet and Pines, 2010a,b).
We measured a sharp increase in FRET signal before NEBD 
and a subsequent decrease in mitosis in Cyclin B1 +/+ and B1 +/− 
embryos injected with Cyclin B1–CaaX (Fig. 7 H). We then as-
sayed whether injecting Cyclin B1–CaaX into Cyclin B1−/− em-
bryos led to any increase in FRET signal and found that there was 
no detectable increase above background fluctuation (Fig. 7 I). To 
test whether membrane-tethered Cyclin B1–Cdk1 could be acti-
vated if we removed the inhibitory phosphorylation on Cdk1, we 
inhibited Wee1 by adding MK1775. As expected, adding MK1775 
to Cyclin B1+/+ and B1+/− embryos caused an almost immediate 
increase in FRET signal, which subsequently increased at a slower 
rate than in nontreated cells entering mitosis (∼20% decrease 
compared with controls, calculated from four independent exper-
iments). This was followed by a noticeably slower decrease after 
NEBD (Fig.  7  J), which we have also observed in human cells 
(unpublished data). Adding MK1775 to Cyclin B1−/− embryos ex-
pressing membrane-tethered Cyclin B1–RFP–Caax, however, had 
no effect on the FRET signal (Fig. 7 K). We conclude that tethering 
Cyclin B1 to the plasma membrane allows it to bind to Cdk1 but 
that the complex is not detectably activated.
In summary, our results show that Cyclin B1 is essen-
tial for mitosis in mammalian cells and that its spatial local-
ization has a crucial role in triggering mitosis at the correct 
time, even when Cdk1 can be regulated by the antagonistic 
Wee1–Myt1–Cdc25 pathways.
Discussion
In this study, we have combined genetic knockouts with live-cell 
imaging of early mouse embryos to make definitive conclusions 
concerning the role of Cyclin B1 in the control of cell division 
in mammalian cells. We show that, unlike other cyclins, Cyclin 
B1 is essential for division right from the start of development, 
because embryos lacking Cyclin B1 arrest at the four-cell stage, 
once they have run out of maternal Cyclin B1. This makes Cy-
clin B1 unique among the cell cycle cyclins (A1, A2, D1, D2, 
D3 E1, and E2), all of which are redundant to some degree 
(Murphy et al., 1997; Liu et al., 1998; Ciemerych et al., 2002; 
Geng et al., 2003; Kozar et al., 2004; Malumbres et al., 2004; 
Kalaszczynska et al., 2009). It places Cyclin B1 with Cdk1 as 
the key essential cell cycle regulators in mammals (Santamaría 
et al., 2007), at least for embryonic development. There could 
be a different requirement in somatic cells, as shown for Cyclin 
A2, which is essential in hematopoietic stem cells, but not in 
fibroblasts (Kalaszczynska et al., 2009).
The clearly defined arrest at the four-cell stage and our 
measurement of Cyclin B1 mRNA levels was consistent with the 
notion that deletion of any essential cell cycle gene should mani-
fest itself soon after the two-cell stage in the mouse, when zygotic 
genome activation promotes the degradation of maternal mRNA 
transcripts (Clegg and Pikó, 1983; Bolton et al., 1984; Hamatani 
et al., 2004; Wang et al., 2004; Lykke-Andersen et al., 2008).
The observation that Cyclin B1–null embryos underwent 
a second division, even with declining pools of maternal RNA, 
was consistent with our results obtained in cultured cells that 
very low amounts of Cyclin B1 were sufficient to trigger entry 
into mitosis (unpublished data). Several recent siRNA studies in 
mammalian tissue culture cells have questioned whether Cyclin 
B1 is required for mitosis, and one suggestion is that Cyclin A2 
and Cyclin B2 can compensate for the absence of Cyclin B1 
(Bellanger et al., 2007; Soni et al., 2008). This conclusion was 
somewhat surprising to us given our previous studies in human 
cells, where we found that Cyclin B2 mainly functions in the 
disassembly and reassembly of the Golgi apparatus (Draviam 
et al., 2001). This could reflect a difference in the requirement 
for Cyclin B1 between embryonic and somatic cells; another 
possibility is that only small amounts of Cyclin B1 can drive 
cells into mitosis, and siRNA depletion cannot reduce Cyclin 
B1 levels below this amount. We show here that only small 
amounts of Cyclin B1 are indeed able to drive cells into mitosis. 
We estimate that this threshold is less than 10% of the normal 
amount of Cyclin B1 in a human epithelial cell and that this is 
also sufficient to drive human cells into mitosis (unpublished 
data). This demonstrates the importance of a true genetic null in 
analyzing the requirement for an enzyme.
Two other strands of evidence also argue against the pos-
sibility that Cyclin A2 and Cyclin B2 can compensate for the 
absence of Cyclin B1. First, in experiments where we treated 
cells with the Wee1 inhibitor, the activity of the Cyclin A–Cdk 
and Cyclin B2–Cdk1 complexes should have also increased, 
but treatment was clearly insufficient to drive entry to mitosis. 
Second, we found that in the absence of Cyclin B1, cells could 
not enter mitosis even when the antagonistic phosphatases were 
inhibited with OA, which, according to current models for the 
controls on mitotic entry, should have greatly reduced the thresh-
old for kinase activity to drive mitosis (Lindqvist et al., 2009).
In our experiments, we have been able to exploit the 
power of a genetic null background in embryos by developing 
a chip for imaging and subsequent genotyping analysis. Thus, 
we could analyze large numbers of embryos that could subse-
quently be reliably genotyped and thereby identify statistically 
significant changes in the timing of cell cycle phases, as well as 
to characterize in detail cell cycle arrest phenotypes and carry 
out structure–function analyses. Given the large number of cell 
cycle regulator mutants that have been generated in the mouse, 
our system opens up the possibility to combine the power of 
mouse genetics with time-lapse imaging to determine how the 
cell cycle is regulated in its natural context.
We have exploited the genetic null background and our 
imaging chip to clarify the importance of the spatial regulation 
of Cyclin B1. Cyclin B1 normally shuttles between the nucleus 
and the cytoplasm such that the great majority of Cyclin B1 
is cytoplasmic until it is activated, but the requirement for this 
nuclear export has been unclear. We find that keeping Cyclin B1 
in the cytoplasm by tethering it to the plasma membrane allows 
it to bind Cdk1 but prevents the complex from being detectably 
activated, even when there is no Wee1/Myt1 activity. Thus it is 
likely that Cyclin B1–Cdk1must be able to diffuse in the cy-
toplasm, or between the cytoplasm and the nucleus, to trigger 
mitosis in the mouse embryo.
We were surprised to find that a constitutively nuclear 
Cyclin B1 triggers mitosis too early, even though its partner, 
Cdk, should still be regulated by the Wee1/Myt1 kinases. Pre-
vious studies expressing nuclear Cyclin B1 in the background 
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Figure 7. Tethering Cyclin B1–Cdk1 to the plasma membrane perturbs its activation. (A–D) Cdk1 antibody staining in Cyclin B1–RFP–Caax mRNA-in-
jected embryos. (A) No primary control. (B) Uninjected embryo showing correct localization of Cdk1 on the spindle during mitosis (right blastomere) and 
throughout the cell in interphase (left two blastomeres). (C and D) Representative example sections showing Cdk1 localization in embryos injected with 
Cyclin B1–RFP–Caax. To test the ability of membrane-bound Cyclin B1 to rescue Cyclin B1−/− embryos, synthetic mRNA encoding wild-type Cyclin B1–
RFP–Caax was injected into one blastomere at the two-cell stage. Representative sections of live embryos at the 32-/64-cell stage for heterozygote (E) and 
knockout (F) genotypes show localization of membrane targeted cyclin B1. (G) Cell numbers in the injected and uninjected side were counted at this stage 
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of endogenous Cyclin B1 in human somatic cells found that 
nuclear Cyclin B1 only caused premature mitosis when coex-
pressed with Wee1/Myt1-insensitive Cdk1AF (Jin et al., 1998). 
Furthermore, our experiments with the MK1775 inhibitor 
showed that the Wee1/Myt1 kinases are also important in mouse 
embryos to prevent S phase and G2 phase cells from triggering 
mitosis. Why cells with nuclear Cyclin B1 cannot prevent pre-
mature mitosis is unclear at this point, in part because the nature 
of the “trigger” to activate Cyclin B1–Cdk1 is undefined. One 
explanation could be that nuclear Cyclin B1 escapes from a neg-
ative regulator, such as Wee1 that is exported to the cytoplasm 
(Li et al., 2010); alternatively, it could meet an activator, such 
as Cdc25. It was notable that nuclear Cyclin B1 was only able 
to shorten G2 phase, which may indicate that S phase and early 
G2 phase cells still regulate nuclear Cyclin B1–Cdk1. Related 
to this, we note that in our experiments, constitutively nuclear 
Cyclin B1 does not interfere with DNA replication. This dif-
fers from the results of experiments in Xenopus embryos where 
nuclear B1 can mediate DNA replication. This could reflect a 
difference between systems or in the properties of the Cyclin B1 
used in the earlier study, because it was fused to the N terminus 
of the S phase–promoting Cyclin E (Moore et al., 2003).
Our results emphasize the importance of spatial control 
in triggering entry to mitosis, and it will be important to de-
termine the dynamics of the subcellular localization of the es-
sential components of the cell cycle machinery in G2 phase to 
determine exactly how the timing of mitotic entry is controlled.
Materials and methods
Embryo collection and culture
To obtain +/+, +/−, and −/− Cyclin B1 embryos, Cyclin B1 heterozy-
gote females were superovulated with 10 IU of pregnant mare’s serum 
gonadotropin (Intervet) and 48  h later with 10 IU human chorionic 
gonadotropin (Intervet) and then mated with Cyclin B1+/− males. The 
same superovulation protocol was used for the analysis of Cyclin B2. 
Cyclin B2−/− mice were crossed with Cyclin B1+/−, and the resulting 
B1+/−B2+/− mice were crossed to obtain Cyclin B1/B2 double-null em-
bryos. Cyclin B1– and B2–knockout mice (Brandeis et al., 1998) were a 
gift of T. Hunt. Zygotes were collected into M2 medium and processed 
as described previously (Jedrusik et al., 2010). Embryos were cultured in 
KSOM medium (Millipore) under paraffin oil in 5% CO2 at 37.5°C. The 
same culture conditions were used during live imaging. This research 
has been regulated under the Animals (Scientific Procedures) Act 1986 
Amendment Regulations 2012 following ethical review by the Univer-
sity of Cambridge Animal Welfare and Ethical Review Body.
Genotyping of embryos
Before the diagnostic PCR, a whole-genome amplification step was 
performed using the illustra GenomiPhi V2 DNA amplification kit 
(GE Healthcare). Embryos were collected into 5 µl GenomiPhi sample 
buffer and stored at −20 °C. Before amplification, samples were heated 
to 95 °C for 5 min and then digested with 5 mg/ml Pronase (Roche) at 
55°C for 12 min. The amplification step was performed according the 
manufacturer’s instructions. All steps before the final PCR were per-
formed in a PCR machine. After amplification samples were purified 
using the QIAquick PCR purification kit (Qiagen).
For diagnostic PCR, the following 10× buffer stock was used: 
ammonium sulfate (NH4)2SO4 (166 mM final), Tris, pH 8.8 (670 mM 
final), MgCl2 (67 mM final), and 100 mM β-mercaptoethanol. Samples 
were run in 50 µl reactions and 3.75 µl DMSO, 0.5 µl Taq Extender 
Additive (Stratagene), and 0.5 µl Platinum Taq polymerase (Invitrogen) 
were added per reaction.
The following primer pairs used for genotyping: Cyclin B1: for-
ward, 5′-ATA CCT AGC CTG AAA CTG AAT CCTT-3′; reverse, 5′-GTC 
CCC AGA AGG TCT TAA AAG TAAC-3′; LacZ: forward, 5′-GCA TCG 
AGC TGG GTA ATA AGC GTT GGC AA-3′; reverse, 5′-GAC ACC AGA 
CCA ACT GGT AAT GGT AGC GAC -3′. Primer pairs used for genotyp-
ing of Cyclin B2: wild-type allele: forward, 5′-CCT TCT CTT AGA ATG 
AGC TGA GTGA-3′; reverse, 5′-ACT AGC CGG GAA GTA AAA GAC 
TG-3′; mutated allele: forward, 5′-AAT TCG CCA ATG ACA AGA CG-
3′; reverse, 5′-ACT AGC CGG GAA GTA AAA GAC TG-3′.
Plasmids and mRNA microinjection
The coding sequences of the following constructs were cloned into 
pBluescript RN3P (Zernicka-Goetz et al., 1997) and verified by 
DNA sequencing: human H2B-RFP, human mRuby-NLS-PCNA, 
wild-type mouse Cyclin B1–Venus, and human export deficient 
Cyclin B1F146A with additional SV40 NLS, wild-type mouse Cyclin 
B1–RFP–Caax (using the following Caax sequence obtained from 
Clontech: 5′-AAG ATG AGC AAA GAT GGT AAA AAG AAG AAA 
AAG AAG TCA AAG ACA AAG TGT GTA ATT ATG TAA-3′), Cdk1 
FRET sensor as described previously (Gavet and Pines, 2010a). The 
sequences of these plasmids are available upon request. mRNAs 
were transcribed in vitro using the mMessage mMachine T3 kit 
(Ambion). mRNA working concentrations were 0.3 µg/µl EB3-GFP, 
0.01 µg/µl H2B-RFP, 0.1 µg/µl mRuby-PCNA, 0.2 µg/µl Cyclin 
B1–Venus, and 0.2 µg/µl nuclear Cyclin B1–Venus. Microinjections 
were performed on an inverted microscope (DM IRB; Leica) using 
a micromanipulation system (Leica). Embryo holding pipettes were 
pulled and polished over a Touch-O-Matic Bunsen burner flame 
from glass capillaries, (GC100-15; Harvard Apparatus) and con-
nected to a hand air pump tube for suction control of embryo hold-
ing, using a CellTram pump (Eppendorf). Injection needles were 
pulled from glass capillaries (GC100TF-10; Harvard Apparatus) 
on a Flaming Brown Micropipette Puller P-97 (Sutter Instrument). 
Injection needles were connected to a FemtoJet compressed air in-
jection system (Eppendorf). The needle holder was connected to an 
Electro 705 electrometer (World Precision Instruments) probe and 
the embryo holder to an earth wire to create negative capacitance 
on the embryonic cell membrane to facilitate needle penetration. 
During injections embryos were held in a drop of M2 medium under 
mineral oil on a depression glass slide.
and the great majority (90%) of injected embryos arrested either at the four-cell stage or before (n = 21, 12 experiments) demonstrating the inability of 
membrane-bound cyclin B1 to rescue B1−/− embryos. (H–K) Embryos injected with Cyclin B1–RFP–Caax mRNA were coinjected with a Cdk1 FRET sensor 
to show changes in levels of Cdk1 phosphorylation. Although Cyclin B1+/+ and Cyclin B1+/− embryos show a normal increase of Cdk1 activation before 
NEBD and a subsequent decrease (H), Cyclin B1−/− embryos remained at randomly fluctuating levels (I). (J and K) To test whether Wee1 inhibition can 
trigger Cdk1 activation in Cyclin B−/− embryos with membrane-tethered Cyclin B1, FRET imaging was performed to detect changes in Cdk1 phosphoryla-
tion. Representative FRET signal graphs aligned to the time point of Wee1 inhibitor (MK 1775) addition. (J) Cyclin B1+/+ and Cyclin B1+/− embryos show a 
clear response after addition of MK1775 (NEBD marked by squares on the graph). (K) Cyclin B1−/− embryos injected with membrane-tethered Cyclin B1 
showed no response in Cdk1 phosphorylation. There was no difference in FRET measurements close to or away from the membrane. Bars, 20 µm. Imaging 
interval in FRET analysis, 8 min.
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Imaging device
To facilitate embryo handling during high-resolution imaging and re-
covery after imaging, we developed a multiwell glass chip that contains 
an array of 252-well chambers open to the medium. This device was 
developed in collaboration with Dolomite Microfluidics, a microfluid-
ics device manufacturer (part 3200208; Dolomite Microfluidics). Well 
dimensions were adjusted for standard optical coverslip thickness and 
embryo stages up to expanded blastocyst. The chip is bonded to a glass 
reservoir to hold medium. Embryos were loaded into and retrieved 
from individual chambers with a fine glass pipette. To mount the de-
vice onto the microscope, it was inserted into a metal interface (part 
3200209; Dolomite Microfluidics) compatible with standard 35-mm 
Petri-dish microscope stage inserts.
Imaging
Time-lapse imaging was performed on a confocal spinning-disk mi-
croscope system (Intelligent Imaging Innovations, Inc. 3i) comprising 
an Observer Z1 inverted microscope (Zeiss), a CSU X1 spinning disk 
head (Yokogawa), and a QuantEM 512SC camera (Photometrics). All 
live-imaging data shown were collected using a 63× NA 1.2 w.corr. 
objective (Zeiss), and for most time-lapse acquisitions, time intervals 
of 8 or 10 min were used. Image acquisition and processing was per-
formed in Slidebook 5 and 6 software. ImageJ was used for additional 
image processing. Confocal imaging of antibody stained samples was 
performed on an SP8 confocal microscope system (Leica).
FRET data analysis
Raw FRET fluorescence intensity data obtained from cytoplasmic and 
membrane regions was analyzed by loading the transmission and donor 
channel data (T(t) and D(t), respectively) and their corresponding back-
ground levels (δT(t) and δD(t)) into commercially available data anal-
ysis software (ORI GIN 9.1; OriginLab). The background levels were 
subtracted from each channel and the resulting signal normalized to 
have a maximum and minimum corresponding to 1 and 0, respectively. 
The background subtracted transmission signal was divided by the 
background subtracted donor signal to give the FRET signal f(t),
  f ( t ) =  [ T ( t ) − δT ( t )  ________D ( t ) − δD ( t )  ] 0 
1
, 
where  […] 0 1 is the contents normalized with a maximum value of 1 and 
a minimum of 0. A Fourier filter was applied to f(t) to remove known 
system noise and fluctuations from the final signal.
Quantitative RT-PCR
Total RNA was extracted from embryos using the Single Cells-to-CT 
qRT-PCR kit (4458236; ThermoFisher). Reverse transcription was 
performed after DNase I treatment in the presence of TaqMan oligo-
nucleotides, and subsequent quantitative PCR was performed accord-
ing to manufacturer’s instructions on a StepOnePlus system (Applied 
Biosystems). All individual quantitative PCR assays were performed 
in triplicate. Primer used were mouse ccnb1 (Mm 00838401-g1; 
ThermoFisher), LacZ (ARX GPZJ; ThermoFisher), and b-Actin 
(Mm02619580-g1; ThemoFisher). Wild-type F1 control samples were 
used to normalize Cyclin B1 mRNA and to determine the background 
levels for LacZ expression. Cyclin B1 and LacZ Ct levels were normal-
ized to the level of mouse b-Actin Ct. Relative RNA levels were calcu-
lated using the formula: ΔΔCT = (MeanCT, Target − MeanCT, Actin)
control − (MeanCT, Target − MeanCT, Actin)Sample. Differences be-
tween samples and controls were compared according the 2^(−ΔΔCt) 
method. The mean and standard error (ΔCt SE) of the mean were deter-
mined from three repeats for each sample.
Western blot analysis
Recombinant mouse His-GST CDK1 and recombinant mouse 10xHis 
CCNB1Myc (Creative BioMart) were used as protein standards and 
loaded at 1, 5, 10 ng per lane.
Wild-type mouse embryo samples containing 130 uninjected 
embryos and 130 embryos injected with CyclinB1–Venus mRNA at 
the zygote stage were harvested at the two-cell stage, and embryo 
extracts were prepared using lysis buffer (150 mM KCl, 20 mM Hepes, 
pH 7.6, 2  mM EGTA, 1.5  mM MgCl2, 50  mM NaF, 0.1% NP-40, 
10% glycerol, 1  mM Na3VO4, 20  mM β-glycerophosphate, 1  mM 
dithiothreitol, 10  mM benzamidine HCl, and 25 U/ml Benzonase 
nuclease [Merck]) supplemented with Protease inhibitor cocktail 
(P2714; Sigma-Aldrich). Protein samples were separated by SDS-
PAGE and analyzed by Western blotting, following standard protocols. 
Transferred nitrocellulose membranes (Immobilon-P Membrane, 
IPVH00010; Merck) were blotted with anti-CDK1 antibody (YE324, 
ab32094; Abcam), anti-Cyclin B1 antibody (EPR17060; ab181593; 
Abcam) and subsequently with protein A/G-HRP (recombinant protein 
A/G, peroxidase conjugated; 32490; Pierce). Scanned images were 
imported into Adobe Photoshop CS6 and the bands were quantified 
using ImageJ 1.49d (https ://imagej .nih .gov /ij /).
Cdk1 whole-mount antibody staining
Embryos were fixed in 4% PFA in PBS, pH 7.5, for 20 min at RT, 
washed three times for 10 min in PBS, permeabilized for 20 min in 
either 0.5% Triton or 0.1% Saponin in PBS, and then washed three 
times 10 min in either 0.1% Tween 20 or 0.1% Saponin in PBS. Block-
ing and primary and secondary antibody staining were performed ei-
ther in 0.1% Tween 20 or 0.1% Saponin with 2% BSA in PBS at 4 
°C overnight. After staining, samples were washed three times in PBS 
and mounted in PBS in a glass-bottom dish for imaging. The primary 
antibody was mouse monoclonal anti-Cdk1 (1:200, POH-1; ab8040; 
Abcam), and the secondary antibody was donkey anti–mouse Alexa 
488 (1:500; a21202; Invitrogen).
Inhibitors
OA powder (Calbiochem) was dissolved in water to a stock concentra-
tion of 125 µM and diluted in equilibrated KSOM to a final concentra-
tion of 250 nM in the imaging device. Wee1 kinase inhibitor (MK1775; 
Axonmedchem) was diluted in DMSO to a stock concentration of 
1 mM and used in equilibrated KSOM at 2 mM and at 20 mM in the 
FRET experiments in Fig. 7.
Online supplemental material
Fig. S1 shows the experimental workflow for the experiments and 
details of the imaging device. Fig. S2 shows representative frames of 
Videos 3–8 showing the effect of OA and MK1775 treatment on chro-
mosome and microtubule behavior. Fig. S3 compares the time point 
of arrest of Cyclin B1−/− and B1−/−/B2−/− embryos. Fig. S4 quantifies 
the amount of Cyclin B1 and CDK1 in embryos. Table S1 quantifies 
the amount of Cyclin B1 mRNA in wild-type and Cyclin B1−/− em-
bryos at the four-cell stage. Videos show differential interference con-
trast imaging (Video 1) and H2B-RFP imaging (Video 2) of wild-type 
and Cyclin B1−/− embryos from the two-cell stage up to the blasto-
cyst stage; H2B-RFP (Videos 3 and 5) and EB3-GFP (Videos 4 and 
5) imaging of OA-treated embryos; PCNA-RFP imaging Video 6) of 
wild-type and Cyclin B1−/− embryos; H2B-RFP imaging of MK1775-
treated embryos (Video 7); Cyclin B1–Venus imaging (Videos 8–10) 
and PCNA-RFP (Video 9) or H2B-RFP imaging (Video 10) in Cyclin 
B1–Venus (Videos 8 and 9), or NLS–Cyclin B1–Venus (Video  10) 
mRNA-injected blastomeres.
 o
n
 N
ovem
ber 1, 2017
jcb.rupress.org
D
ow
nloaded from
 
JCB﻿﻿  • 201814
Acknowledgments
We are very grateful to Jane Kirk and Tim Hunt for the gift of the Cyclin 
B1+/− and Cyclin B2−/− mouse strains. We thank all members of both 
our laboratories for help and advice. 
This work was supported by a Wellcome Trust Senior Fellowship 
to M. Zernicka-Goetz and subsequently by a program grant from the 
Medical Research Council to J.  Pines. Both M. Zernicka-Goetz and 
J. Pines acknowledge core funding provided by the Wellcome Trust 
(092096) and Cancer Research UK (C6946/A14492). 
The authors declare no competing financial interests.
Submitted: 20 December 2016
Revised: 2 August 2017
Accepted: 21 September 2017
References
Bellanger, S., A.  de Gramont, and J.  Sobczak-Thepot. 2007. Cyclin B2 sup-
presses mitotic failure and DNA re-replication in human somatic cells 
knocked down for both cyclins B1 and B2. Oncogene. 26:7175–7184.
Bischoff, M., D.E.  Parfitt, and M.  Zernicka-Goetz. 2008. Formation of the 
embryonic-abembryonic axis of the mouse blastocyst: relationships 
between orientation of early cleavage divisions and pattern of symmetric/
asymmetric divisions. Development. 135:953–962. https ://doi .org /10 
.1242 /dev .014316
Bolton, V.N., P.J.  Oades, and M.H.  Johnson. 1984. The relationship between 
cleavage, DNA replication, and gene expression in the mouse 2-cell em-
bryo. J. Embryol. Exp. Morphol. 79:139–163.
Brandeis, M., I. Rosewell, M. Carrington, T. Crompton, M.A. Jacobs, J. Kirk, 
J. Gannon, and T. Hunt. 1998. Cyclin B2-null mice develop normally and 
are fertile whereas cyclin B1-null mice die in utero. Proc. Natl. Acad. Sci. 
USA. 95:4344–4349. https ://doi .org /10 .1073 /pnas .95 .8 .4344
Castilho, P.V., B.C. Williams, S. Mochida, Y. Zhao, and M.L. Goldberg. 2009. 
The M phase kinase Greatwall (Gwl) promotes inactivation of PP2A/
B55delta, a phosphatase directed against CDK phosphosites. Mol. Biol. 
Cell. 20:4777–4789. https ://doi .org /10 .1091 /mbc .E09 -07 -0643
Chang, H.-Y., P.C.  Jennings, J.  Stewart, N.M.  Verrills, and K.T.  Jones. 2011. 
Essential role of protein phosphatase 2A in metaphase II arrest and 
activation of mouse eggs shown by okadaic acid, dominant negative 
protein phosphatase 2A, and FTY720. J. Biol. Chem. 286:14705–14712. 
https ://doi .org /10 .1074 /jbc .M110 .193227
Ciemerych, M.A., A.M. Kenney, E. Sicinska, I. Kalaszczynska, R.T. Bronson, 
D.H. Rowitch, H. Gardner, and P. Sicinski. 2002. Development of mice 
expressing a single D-type cyclin. Genes Dev. 16:3277–3289. https ://doi 
.org /10 .1101 /gad .1023602
Clegg, K.B., and L.  Pikó. 1983. Quantitative aspects of RNA synthesis and 
polyadenylation in 1-cell and 2-cell mouse embryos. J.  Embryol. Exp. 
Morphol. 74:169–182.
Day, M.L., M.H. Johnson, and D.I. Cook. 1998. A cytoplasmic cell cycle controls 
the activity of a K+ channel in pre-implantation mouse embryos. EMBO 
J. 17:1952–1960. https ://doi .org /10 .1093 /emboj /17 .7 .1952
Draviam, V.M., S.  Orrechia, M.  Lowe, R.  Pardi, and J.  Pines. 2001. The 
localization of human cyclins B1 and B2 determines CDK1 substrate 
specificity and neither enzyme requires MEK to disassemble the Golgi 
apparatus. J.  Cell Biol. 152:945–958. https ://doi .org /10 .1083 /jcb .152 .5 
.945
Enoch, T., and P. Nurse. 1990. Mutation of fission yeast cell cycle control genes 
abolishes dependence of mitosis on DNA replication. Cell. 60:665–673. 
https ://doi .org /10 .1016 /0092 -8674(90)90669 -6
Gavet, O., and J. Pines. 2010a. Activation of cyclin B1-Cdk1 synchronizes events 
in the nucleus and the cytoplasm at mitosis. J. Cell Biol. 189:247–259. 
https ://doi .org /10 .1083 /jcb .200909144
Gavet, O., and J.  Pines. 2010b. Progressive activation of CyclinB1-Cdk1 
coordinates entry to mitosis. Dev. Cell. 18:533–543. https ://doi .org /10 
.1016 /j .devcel .2010 .02 .013
Geng, Y., Q.  Yu, E.  Sicinska, M.  Das, J.E.  Schneider, S.  Bhattacharya, 
W.M. Rideout, R.T. Bronson, H. Gardner, and P. Sicinski. 2003. Cyclin E 
ablation in the mouse. Cell. 114:431–443. https ://doi .org /10 .1016 /S0092 
-8674(03)00645 -7
Gharbi-Ayachi, A., J.-C.  Labbé, A.  Burgess, S.  Vigneron, J.-M.  Strub, 
E.  Brioudes, A.  Van-Dorsselaer, A.  Castro, and T.  Lorca. 2010. The 
Substrate of Greatwall Kinase, Arpp19, Controls Mitosis by Inhibiting 
Protein Phosphatase 2A. Science. 330:1673–1677.
Gong, D., and J.E.J. Ferrell Jr. 2010. The roles of cyclin A2, B1, and B2 in early 
and late mitotic events. Mol. Biol. Cell. 21:3149–3161. https ://doi .org /10 
.1091 /mbc .E10 -05 -0393
Gong, D., J.R. Pomerening, J.W. Myers, C. Gustavsson, J.T. Jones, A.T. Hahn, 
T.  Meyer, and J.E.J.  Ferrell Jr. 2007. Cyclin A2 regulates nuclear-
envelope breakdown and the nuclear accumulation of cyclin B1. Curr. 
Biol. 17:85–91. https ://doi .org /10 .1016 /j .cub .2006 .11 .066
Goval, J.J., and H.  Alexandre. 2000. Effect of genistein on the temporal 
coordination of cleavage and compaction in mouse preimplantation 
embryos. Eur. J.  Morphol. 38:88–96. https ://doi .org /10 .1076 /0924 
-3860(200004)38 :2;1 -F;FT088
Hagting, A., C.  Karlsson, P.  Clute, M.  Jackman, and J.  Pines. 1998. MPF 
localization is controlled by nuclear export. EMBO J.  17:4127–4138. 
https ://doi .org /10 .1093 /emboj /17 .14 .4127
Hamatani, T., M.G. Carter, A.A. Sharov, and M.S. Ko. 2004. Dynamics of global 
gene expression changes during mouse preimplantation development. 
Dev. Cell. 6:117–131. https ://doi .org /10 .1016 /S1534 -5807(03)00373 -3
Hirai, H., Y.  Iwasawa, M.  Okada, T.  Arai, T.  Nishibata, M.  Kobayashi, 
T.  Kimura, N.  Kaneko, J.  Ohtani, K.  Yamanaka, et al. 2009. Small-
molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes 
p53-deficient tumor cells to DNA-damaging agents. Mol. Cancer Ther. 
8:2992–3000. https ://doi .org /10 .1158 /1535 -7163 .MCT -09 -0463
Jackman, M., M. Firth, and J. Pines. 1995. Human cyclins B1 and B2 are local-
ized to strikingly different structures: B1 to microtubules, B2 primarily to 
the Golgi apparatus. EMBO J. 14:1646–1654.
Jacobs, H.W., J.A. Knoblich, and C.F. Lehner. 1998. Drosophila Cyclin B3 is 
required for female fertility and is dispensable for mitosis like Cyclin 
B. Genes Dev. 12:3741–3751. https ://doi .org /10 .1101 /gad .12 .23 .3741
Jedrusik, A., A.W. Bruce, M.H. Tan, D.E. Leong, M. Skamagki, M. Yao, and 
M.  Zernicka-Goetz. 2010. Maternally and zygotically provided Cdx2 
have novel and critical roles for early development of the mouse embryo. 
Dev. Biol. 344:66–78. https ://doi .org /10 .1016 /j .ydbio .2010 .04 .017
Jin, P., S.  Hardy, and D.O.  Morgan. 1998. Nuclear localization of cyclin B1 
controls mitotic entry after DNA damage. J.  Cell Biol. 141:875–885. 
https ://doi .org /10 .1083 /jcb .141 .4 .875
Kalaszczynska, I., Y. Geng, T. Iino, S. Mizuno, Y. Choi, I. Kondratiuk, D.P. Silver, 
D.J. Wolgemuth, K. Akashi, and P. Sicinski. 2009. Cyclin A is redundant 
in fibroblasts but essential in hematopoietic and embryonic stem cells. 
Cell. 138:352–365. https ://doi .org /10 .1016 /j .cell .2009 .04 .062
Kozar, K., M.A.  Ciemerych, V.I.  Rebel, H.  Shigematsu, A.  Zagozdzon, 
E. Sicinska, Y. Geng, Q. Yu, S. Bhattacharya, R.T. Bronson, et al. 2004. 
Mouse development and cell proliferation in the absence of D-cyclins. 
Cell. 118:477–491. https ://doi .org /10 .1016 /j .cell .2004 .07 .025
Lehner, C.F., and P.H. O’Farrell. 1990. The roles of Drosophila cyclins A and 
B in mitotic control. Cell. 61:535–547. https ://doi .org /10 .1016 /0092 
-8674(90)90535 -M
Leonhardt, H., H.P. Rahn, P. Weinzierl, A. Sporbert, T. Cremer, D. Zink, and 
M.C.  Cardoso. 2000. Dynamics of DNA replication factories in living 
cells. J. Cell Biol. 149:271–280. https ://doi .org /10 .1083 /jcb .149 .2 .271
Li, C., M.  Andrake, R.  Dunbrack, and G.H.  Enders. 2010. A bifunctional 
regulatory element in human somatic Wee1 mediates cyclin A/Cdk2 
binding and Crm1-dependent nuclear export. Mol. Cell. Biol. 30:116–
130. https ://doi .org /10 .1128 /MCB .01876 -08
Lindqvist, A., V.  Rodriguez-Bravo, and R.H.  Medema. 2009. The decision to 
enter mitosis: Feedback and redundancy in the mitotic entry network. 
J. Cell Biol. 185:193–202.
Liu, D., M.M. Matzuk, W.K. Sung, Q. Guo, P. Wang, and D.J. Wolgemuth. 1998. 
Cyclin A1 is required for meiosis in the male mouse. Nat. Genet. 20:377–
380. https ://doi .org /10 .1038 /3855
Liu, D., C. Liao, and D.J. Wolgemuth. 2000. A role for cyclin A1 in the activation 
of MPF and G2-M transition during meiosis of male germ cells in mice. 
Dev. Biol. 224:388–400. https ://doi .org /10 .1006 /dbio .2000 .9776
Lykke-Andersen, K., M.J.  Gilchrist, J.B.  Grabarek, P.  Das, E.  Miska, and 
M.  Zernicka-Goetz. 2008. Maternal Argonaute 2 is essential for early 
mouse development at the maternal-zygotic transition. Mol. Biol. Cell. 
19:4383–4392. https ://doi .org /10 .1091 /mbc .E08 -02 -0219
Malumbres, M., R.  Sotillo, D.  Santamaría, J.  Galán, A.  Cerezo, S.  Ortega, 
P.  Dubus, and M.  Barbacid. 2004. Mammalian cells cycle without the 
D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell. 118:493–504. 
https ://doi .org /10 .1016 /j .cell .2004 .08 .002
Mochida, S., S.L. Maslen, M. Skehel, and T. Hunt. 2010. Greatwall phosphory-
lates an inhibitor of protein phosphatase 2A that is essential for mitosis. 
Science. 330:1670–1673.
 o
n
 N
ovem
ber 1, 2017
jcb.rupress.org
D
ow
nloaded from
 
Cyclin B1 is essential for cells to enter mitosis • Strauss et al. 15
Moore, J.D., J.A. Kirk, and T. Hunt. 2003. Unmasking the S-phase-promoting 
potential of cyclin B1. Science. 300:987–990.
Morgan, D.O. 2007. The Cell Cycle: Principles of Control. Oxford University 
Press, Oxford, UK. 297 pp.
Murphy, M., M.G. Stinnakre, C. Senamaud-Beaufort, N.J. Winston, C. Sweeney, 
M. Kubelka, M. Carrington, C. Bréchot, and J. Sobczak-Thépot. 1997. 
Delayed early embryonic lethality following disruption of the murine 
cyclin A2 gene. Nat. Genet. 15:83–86. https ://doi .org /10 .1038 /ng0197 -83
Nguyen, T.B., K.  Manova, P.  Capodieci, C.  Lindon, S.  Bottega, X.-Y.  Wang, 
J.  Refik-Rogers, J.  Pines, D.J.  Wolgemuth, and A.  Koff. 2002. 
Characterization and expression of mammalian cyclin b3, a prepachytene 
meiotic cyclin. J. Biol. Chem. 277:41960–41969. https ://doi .org /10 .1074 
/jbc .M203951200
Noton, E., and J.F. Diffley. 2000. CDK inactivation is the only essential function 
of the APC/C and the mitotic exit network proteins for origin resetting 
during mitosis. Mol. Cell. 5:85–95. https ://doi .org /10 .1016 /S1097 
-2765(00)80405 -0
O’Connell, M.J., J.M. Raleigh, H.M. Verkade, and P. Nurse. 1997. Chk1 is a 
wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 
phosphorylation. EMBO J.  16:545–554. https ://doi .org /10 .1093 /emboj 
/16 .3 .545
Russell, P., and P. Nurse. 1987. Negative regulation of mitosis by wee1+, a gene 
encoding a protein kinase homolog. Cell. 49:559–567. https ://doi .org /10 
.1016 /0092 -8674(87)90458 -2
Santamaría, D., C.  Barrière, A.  Cerqueira, S.  Hunt, C.  Tardy, K.  Newton, 
J.F. Cáceres, P. Dubus, M. Malumbres, and M. Barbacid. 2007. Cdk1 is 
sufficient to drive the mammalian cell cycle. Nature. 448:811–815. https 
://doi .org /10 .1038 /nature06046
Santos, S.D., R. Wollman, T. Meyer, and J.E.J. Ferrell Jr. 2012. Spatial positive 
feedback at the onset of mitosis. Cell. 149:1500–1513. https ://doi .org /10 
.1016 /j .cell .2012 .05 .028
Soni, D.V., R.M. Sramkoski, M. Lam, T. Stefan, and J.W.  Jacobberger. 2008. 
Cyclin B1 is rate limiting but not essential for mitotic entry and progres-
sion in mammalian somatic cells. Cell Cycle. 7:1285–1300.
Streffer, C., D. van Beuningen, M. Molls, N. Zamboglou, and S. Schulz. 1980. 
Kinetics of cell proliferation in the pre-implanted mouse embryo in vivo 
and in vitro. Cell Tissue Kinet. 13:135–143.
Toyoshima, F., T.  Moriguchi, A.  Wada, M.  Fukuda, and E.  Nishida. 1998. 
Nuclear export of cyclin B1 and its possible role in the DNA damage-
induced G2 checkpoint. EMBO J. 17:2728–2735. https ://doi .org /10 .1093 
/emboj /17 .10 .2728
van Vugt, M.A., A. Brás, and R.H. Medema. 2004. Polo-like kinase-1 controls 
recovery from a G2 DNA damage-induced arrest in mammalian cells. 
Mol. Cell. 15:799–811. https ://doi .org /10 .1016 /j .molcel .2004 .07 .015
Wang, Q.T., K.  Piotrowska, M.A.  Ciemerych, L.  Milenkovic, M.P.  Scott, 
R.W. Davis, and M. Zernicka-Goetz. 2004. A genome-wide study of gene 
activity reveals developmental signaling pathways in the preimplantation 
mouse embryo. Dev. Cell. 6:133–144. https ://doi .org /10 .1016 /S1534 
-5807(03)00404 -0
Yang, J., E.S. Bardes, J.D. Moore, J. Brennan, M.A. Powers, and S. Kornbluth. 
1998. Control of cyclin B1 localization through regulated binding of the 
nuclear export factor CRM1. Genes Dev. 12:2131–2143. https ://doi .org 
/10 .1101 /gad .12 .14 .2131
Zernicka-Goetz, M., J. Pines, S. McLean Hunter, J.P. Dixon, K.R. Siemering, 
J. Haseloff, and M.J. Evans. 1997. Following cell fate in the living mouse 
embryo. Development. 124:1133–1137.
 o
n
 N
ovem
ber 1, 2017
jcb.rupress.org
D
ow
nloaded from
 
